CBIH Commences Clinical Trials of Osteoarthritis Injection “Orthocann”
![CBIH Commences Clinical Trials of Osteoarthritis Injection “Orthocann”](https://www.cannabisindustry.news/wp-content/uploads/2024/03/83559c51-ae7e-5bc0-8e62-6285616fdb99-34-850x560.png)
(marketscreener.com) Cannabis Bioscience International Holdings, Inc. has announced the enrollment of the first patient for the clinical trial of its new intra-articular cannabinoid-based injection for knee osteoarthritis. The company plans to test the produc…
Houston, Texas–(Newsfile Corp. – March 20, 2024) – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) has announced the enrollment of the first patient for the clinical trial of its n…